Koch C, Rainisio M, Madessani U, Harms H K, Hodson M E, Mastella G, McKenzie S G, Navarro J, Strandvik B
Department of Pediatrics, Rigshospitalet, University Hospital, Copenhagen, Denmark.
Pediatr Pulmonol. 2001 Nov;32(5):343-50. doi: 10.1002/ppul.1142.
Data derived from a cross-sectional analysis of 7,566 patients stratified into six age groups were used to compare lung function, body mass index (BMI), and weight for age in patients with and without cystic fibrosis-related diabetes mellitus (CFDM). The presence of CFDM was tightly linked to poor lung function, regardless of age. The mean value of FEV(1) % predicted in the age groups < 10, 10-< 15, 15-< 20, 20-< 25, 25-< 30, and 30 years or older were 87%, 77%, 69%, 58%, 55%, and 53% in the nondiabetic cystic fibrosis (CF) patients as compared to 79%, 66%, 55%, 49%, 46%, and 44% in the diabetic CF patients. BMI and weight for age were also lower in diabetic than nondiabetic CF patients in all age groups, except for BMI in the youngest patients. The difference in lung function and in nutritional parameters between diabetic and nondiabetic CF patients was not linked to presence or absence of any specific pathogen in the lower respiratory tract. These results confirm and extend those of earlier studies in smaller numbers of patients, and they clearly identify CFDM as a powerful determinant of severe lung disease and reduced survival in patients with CF and diabetes mellitus.
对7566名患者进行横断面分析,将其分为六个年龄组,所得数据用于比较患有和未患有囊性纤维化相关糖尿病(CFDM)患者的肺功能、体重指数(BMI)和年龄别体重。无论年龄大小,CFDM的存在都与肺功能差密切相关。在年龄小于10岁、10至小于15岁、15至小于20岁、20至小于25岁、25至小于30岁以及30岁及以上的年龄组中,非糖尿病囊性纤维化(CF)患者的预计FEV(1)%平均值分别为87%、77%、69%、58%、55%和53%,而糖尿病CF患者的相应值分别为79%、66%、55%、49%、46%和44%。除最年轻患者的BMI外,所有年龄组中糖尿病CF患者的BMI和年龄别体重也均低于非糖尿病CF患者。糖尿病和非糖尿病CF患者在肺功能和营养参数方面的差异与下呼吸道中是否存在任何特定病原体无关。这些结果证实并扩展了早期对较少患者数量的研究结果,并且明确将CFDM确定为CF合并糖尿病患者严重肺部疾病和生存率降低的一个重要决定因素。